Oppenheimer & Co. Inc. boosted its holdings in McKesson Co. (NYSE:MCK) by 46.2% in the third quarter, HoldingsChannel reports. The firm owned 2,357 shares of the company’s stock after buying an additional 745 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in McKesson were worth $313,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Fort L.P. acquired a new stake in shares of McKesson in the second quarter valued at approximately $110,000. Flagship Harbor Advisors LLC acquired a new stake in shares of McKesson in the second quarter valued at approximately $118,000. Reilly Financial Advisors LLC boosted its holdings in shares of McKesson by 506.8% in the third quarter. Reilly Financial Advisors LLC now owns 898 shares of the company’s stock valued at $119,000 after acquiring an additional 750 shares during the period. Squar Milner Financial Services LLC acquired a new stake in shares of McKesson in the second quarter valued at approximately $179,000. Finally, Sun Life Financial INC boosted its holdings in shares of McKesson by 450.6% in the second quarter. Sun Life Financial INC now owns 1,349 shares of the company’s stock valued at $180,000 after acquiring an additional 1,104 shares during the period. 89.19% of the stock is owned by hedge funds and other institutional investors.

MCK has been the subject of several research analyst reports. ValuEngine raised McKesson from a “strong sell” rating to a “sell” rating in a report on Monday, October 29th. Mizuho restated a “hold” rating and set a $133.00 price target on shares of McKesson in a research note on Sunday, August 12th. Royal Bank of Canada set a $155.00 price target on McKesson and gave the stock a “hold” rating in a research note on Friday, October 26th. Jefferies Financial Group restated a “buy” rating and set a $160.00 price target on shares of McKesson in a research note on Friday, July 27th. Finally, Citigroup cut their price target on McKesson from $160.00 to $2.86 and set a “buy” rating for the company in a research note on Friday, July 20th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $150.26.

McKesson stock opened at $130.81 on Friday. McKesson Co. has a 12 month low of $117.19 and a 12 month high of $178.86. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.99 and a quick ratio of 0.56. The company has a market cap of $25.93 billion, a PE ratio of 9.90, a P/E/G ratio of 1.51 and a beta of 1.05.

McKesson (NYSE:MCK) last released its quarterly earnings results on Thursday, October 25th. The company reported $3.60 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.28 by $0.32. The business had revenue of $53.08 billion during the quarter, compared to analysts’ expectations of $53.56 billion. McKesson had a return on equity of 26.55% and a net margin of 0.06%. As a group, sell-side analysts anticipate that McKesson Co. will post 13.41 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 2nd. Shareholders of record on Monday, December 3rd will be given a $0.39 dividend. This represents a $1.56 annualized dividend and a yield of 1.19%. The ex-dividend date is Friday, November 30th. McKesson’s payout ratio is 12.36%.

In other McKesson news, Director N Anthony Coles sold 1,350 shares of the stock in a transaction on Friday, August 31st. The stock was sold at an average price of $128.69, for a total value of $173,731.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.87% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was reported by Daily Political and is the property of of Daily Political. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://www.dailypolitical.com/2018/11/10/mckesson-co-mck-shares-bought-by-oppenheimer-co-inc.html.

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Read More: Analyzing a company’s cash flow statement

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.